Pre-injection Testing Sample Clauses

Pre-injection Testing. Prior to the first injection of Biomethane into the LDC System, or other NW Natural owned and operated facilities, Producer will hire an independent certified third party laboratory (Oregon Environmental Laboratory Accreditation Program [ORELAP] certified, or equivalent in another state, where applicable) to perform two pre-injection tests (“Pre-Injection Testing”). Samples for each test will be taken a minimum of fourteen (14) days apart and from the flow of gas to the Receipt Point Facilities prior to receipt of Biomethane at the Receipt Point Facilities. Producer will provide NW Natural with a minimum of two (2) business days’ advance notice of the Biomethane sampling and NW Natural will have the option to have a representative present to observe the samples being taken. Samples will be tested for all Constituents specified in Table 1 in Exhibit C according to the feedstock. Test results will be shared with NW Natural within five (5) business days of Producer's receipt of the test results. Producer is responsible for identifying an independent third-party certified laboratory that is capable of detecting constituents at levels specified in Table 1 – Constituent Concentrations, attached in Exhibit C. NW Natural reserves the right to specify a certified laboratory in the event Producer is unable to do so. Test results from the second pre-injection test will identify the Group 1 and Group 2 Health Constituents for Periodic Testing. During Pre-Injection Testing, the Biomethane’s collective potential cancer risk and non-cancer risk totals will be calculated for the Group 2 Health Constituents: Cancer Risk: the sum of the ratios for each carcinogenic constituent measured over the Trigger Level identified in Table 1 in Exhibit C. The ratio is the measured value divided by the trigger level (See formula in Table 2 in Exhibit C). Non-Cancer Risk: the sum of the health indexes of each non-carcinogenic constituent that registers over the Trigger Level identified in Table 1 in Exhibit C. The health index is the measured value divided by the Trigger Level multiplied by 0.1 (See formula in Table 2 in Exhibit C). If the collective potential cancer risk or non-cancer risk is at or above the Risk Level A values defined in Table 2 - Collective Risk from Carcinogenic and Non-carcinogenic Constituents, attached in Exhibit C, the Biomethane cannot be accepted or transported by the LDC System. Producer will make necessary modifications to lower the collective potential cance...
View SourceView Similar (3)

Related to Pre-injection Testing

  • ODUF Testing 6.6.1 Upon request from TWTC, AT&T shall send ODUF test files to TWTC. The Parties agree to review and discuss the ODUF file content and/or format. For testing of usage results, AT&T shall request that TWTC set up a production (live) file. The live test may consist of TWTC’s employees making test calls for the types of services TWTC requests on ODUF. These test calls are logged by TWTC, and the logs are provided to AT&T. These logs will be used to verify the files. Testing will be completed within thirty (30) days from the date on which the initial test file was sent.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.

  • Substance Abuse Testing The Parties agree that it is in the best interest of all concerned to promote a safe working environment. The Union has no objection to pre-employment substance abuse testing when required by the Employer and further, the Union has no objection to voluntary substance abuse testing to qualify for employment on projects when required by a project owner. The cost and scheduling of such testing shall be paid for and arranged by the Employer. The Union agrees to reimburse the Employer for any failed pre-access Alcohol and Drug test costs.

  • Inspection/Testing In order to assess Supplier’s work quality and/or compliance with this Order, upon reasonable notice by Buyer: (a) all goods, materials and services related to the items purchased hereunder, including, raw materials, components, assemblies, work in process, tools and end products shall be subject to inspection and testing by Buyer, its customer, representative or regulatory authorities at all places, including sites where the goods are made or located or the services are performed, whether at Supplier’s premises or elsewhere; and (b) all of Supplier’s facilities, books and records relating to this Order shall be subject to inspection by Buyer or its designee. If specific Buyer and/or Buyer’s customer tests, inspection and/or witness points are included in this Order, the goods shall not be shipped without an inspector’s release or a written waiver of test/inspection/witness with respect to each such point; however, Buyer shall not be permitted to unreasonably delay shipment; and Supplier shall notify Buyer in writing at least twenty (20) days prior to each of Supplier’s scheduled final and, if applicable, intermediate test/inspection/witness points. Supplier agrees to cooperate with such/audit inspection including, completing and returning questionnaires and making available its knowledgeable representatives. Buyer’s failure to inspect or test goods, materials or services or Buyer’s failure to reject or detect defects by inspection or testing shall not relieve Supplier from its warranty obligations or any of its other obligations or responsibilities under this Order. Supplier agrees to provide small business as well as minority and/or women owned business utilization and demographic data upon request.

  • Random Testing Notwithstanding any provisions of the Collective Agreement or any special agreements appended thereto, section 4.6 of the Canadian Model will not be applied by agreement. If applied to a worker dispatched by the Union, it will be applied or deemed to be applied unilaterally by the Employer. The Union retains the right to grieve the legality of any imposition of random testing in accordance with the Grievance Procedure set out in this Collective Agreement.